Inno-Gene SA
WSE:IGN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
STAR CM Holdings Ltd
HKEX:6698
|
CN |
Inno-Gene SA
Depreciation & Amortization
Inno-Gene SA
Depreciation & Amortization Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
I
|
Inno-Gene SA
WSE:IGN
|
Depreciation & Amortization
zł149k
|
CAGR 3-Years
-40%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
N
|
Nanogroup SA
WSE:NNG
|
Depreciation & Amortization
zł75.9k
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
N/A
|
|
|
M
|
Medicofarma Biotech SA
WSE:MDB
|
Depreciation & Amortization
zł1.5m
|
CAGR 3-Years
18%
|
CAGR 5-Years
81%
|
CAGR 10-Years
N/A
|
|
|
R
|
Ryvu Therapeutics SA
WSE:RVU
|
Depreciation & Amortization
zł9.9m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
11%
|
|
|
S
|
Selvita SA
WSE:SLV
|
Depreciation & Amortization
zł54.8m
|
CAGR 3-Years
13%
|
CAGR 5-Years
35%
|
CAGR 10-Years
N/A
|
|
Inno-Gene SA
Glance View
Inno Gene SA engages in the management of startup biotechnology companies. The company is headquartered in Poznan, Woj. Wielkopolskie. The company went IPO on 2011-02-08. Inno-Gene SA’s portfolio comprises of Centrum Badan DNA Sp. z o.o., a company that provides services in the field of genetic medical diagnostics, including microbiological diagnosis of infection and the suitability of human congenital diseases using tests performed on DNA microarray technology. On March 22, 2013, the Company established a new subsidiary, Centrum Edukacji Bio-Medycznej Sp. z o.o. On April 11, 2013, the Company established two new indirect subsidiaries, Genomix Sp. z o.o. and Madgenetix Sp. z o.o. In addition, it operates through VitainSillica Sp z o o.
See Also
What is Inno-Gene SA's Depreciation & Amortization?
Depreciation & Amortization
149k
PLN
Based on the financial report for Jun 30, 2024, Inno-Gene SA's Depreciation & Amortization amounts to 149k PLN.
What is Inno-Gene SA's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 3Y
-40%
Over the last year, the Depreciation & Amortization growth was -64%. The average annual Depreciation & Amortization growth rates for Inno-Gene SA have been -40% over the past three years .
